These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 34916564)
1. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes. Guo J; Li X; Shen S; Wu X Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564 [TBL] [Abstract][Full Text] [Related]
2. Development of an immune-related prognostic index associated with osteosarcoma. Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790 [TBL] [Abstract][Full Text] [Related]
3. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma. Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858 [TBL] [Abstract][Full Text] [Related]
4. Prediction of Prognosis and Immunotherapy Response with a Novel Natural Killer Cell Marker Genes Signature in Osteosarcoma. Li Q; Huang X; Zhao Y Cancer Biother Radiopharm; 2024 Sep; 39(7):502-516. PubMed ID: 37889617 [No Abstract] [Full Text] [Related]
5. Comprehensive investigation of tumor immune microenvironment and prognostic biomarkers in osteosarcoma through integrated bulk and single-cell transcriptomic analysis. Shi S; Zhang L; Guo X Front Immunol; 2024; 15():1424950. PubMed ID: 39108264 [TBL] [Abstract][Full Text] [Related]
6. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma. Wu G; Zhang M BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271 [TBL] [Abstract][Full Text] [Related]
7. TYROBP, TLR4 and ITGAM regulated macrophages polarization and immune checkpoints expression in osteosarcoma. Liang T; Chen J; Xu G; Zhang Z; Xue J; Zeng H; Jiang J; Chen T; Qin Z; Li H; Ye Z; Nie Y; Liu C; Zhan X Sci Rep; 2021 Sep; 11(1):19315. PubMed ID: 34588497 [TBL] [Abstract][Full Text] [Related]
8. Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients. Wan Y; Qu N; Yang Y; Ma J; Li Z; Zhang Z Bioengineered; 2021 Dec; 12(1):5916-5931. PubMed ID: 34488541 [TBL] [Abstract][Full Text] [Related]
9. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients. Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792 [TBL] [Abstract][Full Text] [Related]
10. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma. Lei T; Qian H; Lei P; Hu Y Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683 [TBL] [Abstract][Full Text] [Related]
11. Development of a Risk Model and Genotyping Patterns Based on Disulfidptosis-Related lncRNAs to Predict Prognosis and Immune Landscape in Osteosarcoma. Zhang K; Lu S; Jiang M; Zou X; Chen C; Lan Y; Zhao H; Ma R; Yan H Front Biosci (Landmark Ed); 2024 May; 29(5):193. PubMed ID: 38812298 [TBL] [Abstract][Full Text] [Related]
12. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma. He L; Yang H; Huang J BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089 [TBL] [Abstract][Full Text] [Related]
13. An immune-related eleven-RNA signature-drived risk score model for prognosis of osteosarcoma metastasis. Teng JS; Wang Y Sci Rep; 2024 Jun; 14(1):13401. PubMed ID: 38862526 [TBL] [Abstract][Full Text] [Related]
14. The prognostic value of ubiquitin/ubiquitin-like-related genes along with immune cell infiltration and clinicopathological features in osteosarcoma. Wen J; Wan L; Chen W; Dong X J Orthop Surg Res; 2024 Jun; 19(1):356. PubMed ID: 38879525 [TBL] [Abstract][Full Text] [Related]
15. Development of an immune-related signature for predicting survival outcome and immunotherapy response in osteosarcoma. Wang Q; Zhang W; Guo Y; Li Y; Fu K Aging (Albany NY); 2021 Nov; 13(21):24155-24170. PubMed ID: 34747719 [TBL] [Abstract][Full Text] [Related]
16. Machine learning survival prediction using tumor lipid metabolism genes for osteosarcoma. Li S; Zheng Z; Wang B Sci Rep; 2024 Jun; 14(1):12934. PubMed ID: 38839983 [TBL] [Abstract][Full Text] [Related]
17. Identification of TNFRSF1A as a potential biomarker for osteosarcoma. Zhang Y; Liu K; Wang J Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759 [TBL] [Abstract][Full Text] [Related]
18. Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma. Chen J; Guo X; Zeng G; Liu J; Zhao B Comput Math Methods Med; 2020; 2020():8081973. PubMed ID: 33082842 [TBL] [Abstract][Full Text] [Related]
19. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms. Li G; Lei J; Xu D; Yu W; Bai J; Wu G Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292 [TBL] [Abstract][Full Text] [Related]
20. Identification of two immune subtypes in osteosarcoma based on immune gene sets. Yang M; Cao Y; Wang Z; Zhang T; Hua Y; Cai Z Int Immunopharmacol; 2021 Jul; 96():107799. PubMed ID: 34162161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]